Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinopathy of Prematurity | 34 | 2024 | 432 | 4.990 |
Why?
|
Artificial Intelligence | 35 | 2024 | 2557 | 2.350 |
Why?
|
Image Processing, Computer-Assisted | 22 | 2024 | 8950 | 1.550 |
Why?
|
Glioblastoma | 15 | 2024 | 3484 | 1.500 |
Why?
|
Brain Neoplasms | 23 | 2024 | 8986 | 1.460 |
Why?
|
Information Storage and Retrieval | 8 | 2015 | 822 | 1.340 |
Why?
|
Natural Language Processing | 7 | 2023 | 1135 | 1.210 |
Why?
|
Diagnostic Imaging | 19 | 2024 | 3527 | 1.070 |
Why?
|
Algorithms | 38 | 2024 | 13981 | 1.070 |
Why?
|
Radiology | 10 | 2024 | 2102 | 0.940 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 5 | 2016 | 1660 | 0.780 |
Why?
|
Uterine Cervical Neoplasms | 5 | 2024 | 2003 | 0.760 |
Why?
|
Magnetic Resonance Imaging | 41 | 2024 | 36290 | 0.750 |
Why?
|
Glioma | 8 | 2022 | 3420 | 0.750 |
Why?
|
Ophthalmoscopy | 8 | 2024 | 171 | 0.730 |
Why?
|
Privacy | 1 | 2023 | 233 | 0.730 |
Why?
|
Diagnostic Techniques, Ophthalmological | 3 | 2018 | 250 | 0.710 |
Why?
|
Solitary Pulmonary Nodule | 3 | 2021 | 270 | 0.660 |
Why?
|
Radiology Information Systems | 4 | 2022 | 528 | 0.620 |
Why?
|
ROC Curve | 15 | 2024 | 3568 | 0.620 |
Why?
|
Software | 9 | 2020 | 4419 | 0.610 |
Why?
|
Papillomavirus Infections | 4 | 2024 | 1607 | 0.600 |
Why?
|
Ophthalmology | 5 | 2023 | 549 | 0.590 |
Why?
|
Retinal Vein | 4 | 2021 | 47 | 0.590 |
Why?
|
Image Interpretation, Computer-Assisted | 12 | 2019 | 3340 | 0.530 |
Why?
|
Telemedicine | 7 | 2023 | 3018 | 0.520 |
Why?
|
Gestational Age | 17 | 2024 | 3565 | 0.490 |
Why?
|
Severity of Illness Index | 9 | 2024 | 15840 | 0.470 |
Why?
|
Retinal Vessels | 6 | 2024 | 836 | 0.470 |
Why?
|
Retina | 6 | 2023 | 2635 | 0.460 |
Why?
|
Gallbladder Neoplasms | 3 | 2011 | 190 | 0.450 |
Why?
|
Humans | 153 | 2024 | 760621 | 0.440 |
Why?
|
Phenylurea Compounds | 1 | 2016 | 529 | 0.440 |
Why?
|
Infant, Newborn | 34 | 2024 | 26181 | 0.430 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 666 | 0.430 |
Why?
|
Medicine | 1 | 2021 | 943 | 0.430 |
Why?
|
Vocabulary, Controlled | 1 | 2014 | 167 | 0.430 |
Why?
|
Retinal Artery | 3 | 2021 | 109 | 0.430 |
Why?
|
Contrast Media | 10 | 2020 | 5305 | 0.420 |
Why?
|
Fundus Oculi | 4 | 2023 | 541 | 0.400 |
Why?
|
Tomography, X-Ray Computed | 15 | 2023 | 20509 | 0.390 |
Why?
|
Head and Neck Neoplasms | 6 | 2020 | 2882 | 0.390 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2017 | 929 | 0.380 |
Why?
|
Tumor Burden | 4 | 2023 | 1895 | 0.380 |
Why?
|
Photography | 6 | 2021 | 530 | 0.380 |
Why?
|
Quinolines | 1 | 2016 | 759 | 0.380 |
Why?
|
Reproducibility of Results | 27 | 2024 | 20080 | 0.370 |
Why?
|
Subtraction Technique | 1 | 2014 | 510 | 0.370 |
Why?
|
Peripheral Arterial Disease | 4 | 2023 | 1306 | 0.360 |
Why?
|
Sensitivity and Specificity | 14 | 2024 | 14660 | 0.350 |
Why?
|
Benchmarking | 6 | 2024 | 1044 | 0.340 |
Why?
|
Radiography, Thoracic | 5 | 2022 | 1296 | 0.330 |
Why?
|
Pattern Recognition, Automated | 5 | 2023 | 994 | 0.320 |
Why?
|
Radiation Oncology | 2 | 2014 | 563 | 0.310 |
Why?
|
Adrenoleukodystrophy | 2 | 2023 | 143 | 0.310 |
Why?
|
Radiotherapy, Conformal | 1 | 2011 | 549 | 0.310 |
Why?
|
Database Management Systems | 1 | 2008 | 258 | 0.280 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2017 | 4024 | 0.280 |
Why?
|
Breast Neoplasms | 6 | 2024 | 21025 | 0.260 |
Why?
|
Databases, Factual | 8 | 2021 | 8035 | 0.260 |
Why?
|
Phantoms, Imaging | 7 | 2023 | 2512 | 0.260 |
Why?
|
Automation | 5 | 2020 | 580 | 0.250 |
Why?
|
Lung Neoplasms | 5 | 2021 | 13262 | 0.250 |
Why?
|
Stroke | 3 | 2023 | 9962 | 0.240 |
Why?
|
Retrospective Studies | 24 | 2024 | 80372 | 0.240 |
Why?
|
Internet | 2 | 2014 | 3078 | 0.220 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2023 | 1215 | 0.220 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5325 | 0.220 |
Why?
|
Medical Informatics | 4 | 2020 | 732 | 0.220 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2008 | 1791 | 0.220 |
Why?
|
Clinical Competence | 2 | 2016 | 4783 | 0.220 |
Why?
|
Mammography | 3 | 2024 | 2427 | 0.220 |
Why?
|
Neonatal Screening | 4 | 2023 | 595 | 0.210 |
Why?
|
User-Computer Interface | 4 | 2015 | 1403 | 0.210 |
Why?
|
Infant, Premature | 9 | 2024 | 2092 | 0.200 |
Why?
|
Survival Analysis | 4 | 2016 | 10182 | 0.200 |
Why?
|
Female | 52 | 2024 | 391270 | 0.200 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9276 | 0.200 |
Why?
|
Lung | 6 | 2022 | 9994 | 0.190 |
Why?
|
Reference Standards | 7 | 2021 | 1004 | 0.190 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2007 | 867 | 0.190 |
Why?
|
Computer Communication Networks | 2 | 2020 | 294 | 0.170 |
Why?
|
Male | 49 | 2024 | 359744 | 0.170 |
Why?
|
Hospital Units | 1 | 2021 | 142 | 0.170 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2023 | 384 | 0.170 |
Why?
|
Cervix Uteri | 1 | 2023 | 582 | 0.170 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2015 | 491 | 0.170 |
Why?
|
Proportional Hazards Models | 4 | 2011 | 12531 | 0.160 |
Why?
|
Hyperemia | 1 | 2020 | 221 | 0.160 |
Why?
|
Observer Variation | 3 | 2018 | 2601 | 0.160 |
Why?
|
Long QT Syndrome | 1 | 2023 | 466 | 0.160 |
Why?
|
Musculoskeletal System | 1 | 2021 | 181 | 0.160 |
Why?
|
Perfusion Imaging | 1 | 2020 | 196 | 0.160 |
Why?
|
Endovascular Procedures | 2 | 2023 | 2165 | 0.160 |
Why?
|
Diverticulitis | 1 | 2021 | 182 | 0.160 |
Why?
|
Postoperative Care | 2 | 2019 | 1479 | 0.160 |
Why?
|
Age Determination by Skeleton | 1 | 2018 | 126 | 0.150 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2021 | 707 | 0.150 |
Why?
|
Documentation | 2 | 2015 | 893 | 0.150 |
Why?
|
Lung Injury | 1 | 2022 | 424 | 0.150 |
Why?
|
Rectal Neoplasms | 2 | 2021 | 1152 | 0.150 |
Why?
|
Statistics as Topic | 2 | 2014 | 2362 | 0.150 |
Why?
|
Dacarbazine | 3 | 2015 | 560 | 0.150 |
Why?
|
Radiotherapy, Intensity-Modulated | 4 | 2016 | 801 | 0.140 |
Why?
|
Radiography | 5 | 2022 | 6965 | 0.140 |
Why?
|
Intestinal Obstruction | 1 | 2021 | 434 | 0.140 |
Why?
|
Early Detection of Cancer | 4 | 2024 | 3202 | 0.140 |
Why?
|
Mass Screening | 3 | 2023 | 5423 | 0.140 |
Why?
|
Macular Degeneration | 1 | 2024 | 1002 | 0.140 |
Why?
|
Cerebellar Neoplasms | 1 | 2022 | 587 | 0.140 |
Why?
|
Medical Record Linkage | 1 | 2018 | 288 | 0.140 |
Why?
|
Forecasting | 3 | 2019 | 2932 | 0.140 |
Why?
|
Medulloblastoma | 1 | 2022 | 679 | 0.140 |
Why?
|
Area Under Curve | 4 | 2021 | 1636 | 0.130 |
Why?
|
Middle Aged | 28 | 2024 | 220352 | 0.130 |
Why?
|
Oxygen | 2 | 2021 | 4193 | 0.130 |
Why?
|
Capillary Permeability | 1 | 2019 | 768 | 0.130 |
Why?
|
Microcirculation | 2 | 2017 | 1278 | 0.130 |
Why?
|
Skin Diseases, Genetic | 1 | 2016 | 49 | 0.130 |
Why?
|
Aged | 27 | 2024 | 169152 | 0.130 |
Why?
|
Rheumatic Diseases | 1 | 2022 | 639 | 0.130 |
Why?
|
Brain | 8 | 2021 | 26951 | 0.130 |
Why?
|
Pharyngeal Muscles | 1 | 2016 | 81 | 0.130 |
Why?
|
Neoplasms | 7 | 2024 | 22072 | 0.130 |
Why?
|
Blood Volume Determination | 1 | 2015 | 41 | 0.130 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2018 | 618 | 0.130 |
Why?
|
Preoperative Period | 1 | 2017 | 555 | 0.130 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2021 | 615 | 0.120 |
Why?
|
Arteries | 2 | 2019 | 1126 | 0.120 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2018 | 2782 | 0.120 |
Why?
|
Polysaccharides, Bacterial | 1 | 2017 | 574 | 0.120 |
Why?
|
Prognosis | 9 | 2024 | 29658 | 0.120 |
Why?
|
Physical Phenomena | 1 | 2014 | 48 | 0.120 |
Why?
|
Radiometry | 1 | 2020 | 813 | 0.120 |
Why?
|
Prostatic Neoplasms | 4 | 2024 | 11345 | 0.120 |
Why?
|
Adult | 25 | 2024 | 219994 | 0.120 |
Why?
|
Appendicitis | 1 | 2021 | 674 | 0.120 |
Why?
|
Medical Records Systems, Computerized | 2 | 2013 | 1191 | 0.120 |
Why?
|
National Cancer Institute (U.S.) | 3 | 2020 | 296 | 0.120 |
Why?
|
India | 1 | 2021 | 2336 | 0.120 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2018 | 471 | 0.120 |
Why?
|
Aneurysm, Ruptured | 1 | 2019 | 460 | 0.110 |
Why?
|
Neovascularization, Pathologic | 3 | 2024 | 2640 | 0.110 |
Why?
|
North America | 3 | 2024 | 1284 | 0.110 |
Why?
|
Quality Assurance, Health Care | 2 | 2014 | 2176 | 0.110 |
Why?
|
Blood-Brain Barrier | 2 | 2017 | 1019 | 0.110 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13630 | 0.110 |
Why?
|
Infant | 11 | 2024 | 36060 | 0.110 |
Why?
|
Biomedical Research | 3 | 2024 | 3426 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 4 | 2023 | 4048 | 0.110 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2017 | 1489 | 0.110 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2016 | 286 | 0.110 |
Why?
|
Computer Literacy | 1 | 2013 | 44 | 0.110 |
Why?
|
Brachial Plexus | 1 | 2014 | 166 | 0.110 |
Why?
|
Cranial Irradiation | 1 | 2015 | 391 | 0.100 |
Why?
|
Gadolinium | 1 | 2017 | 959 | 0.100 |
Why?
|
Low Back Pain | 1 | 2021 | 979 | 0.100 |
Why?
|
Organs at Risk | 1 | 2014 | 358 | 0.100 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1231 | 0.100 |
Why?
|
Blood Vessels | 1 | 2017 | 1112 | 0.100 |
Why?
|
Brain Diseases | 1 | 2021 | 1540 | 0.100 |
Why?
|
Otorhinolaryngologic Neoplasms | 1 | 2011 | 26 | 0.100 |
Why?
|
SEER Program | 3 | 2011 | 1530 | 0.100 |
Why?
|
Bayes Theorem | 2 | 2016 | 2326 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2023 | 3484 | 0.090 |
Why?
|
Linear Models | 1 | 2021 | 5877 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2023 | 1941 | 0.090 |
Why?
|
Computer-Assisted Instruction | 1 | 2014 | 362 | 0.090 |
Why?
|
Vascular Malformations | 1 | 2016 | 464 | 0.090 |
Why?
|
Fibrosis | 1 | 2017 | 2042 | 0.090 |
Why?
|
Arteriovenous Malformations | 1 | 2013 | 397 | 0.090 |
Why?
|
Models, Biological | 4 | 2024 | 9467 | 0.090 |
Why?
|
Deglutition Disorders | 1 | 2016 | 626 | 0.090 |
Why?
|
Brain Ischemia | 1 | 2023 | 3127 | 0.080 |
Why?
|
Nomograms | 1 | 2011 | 238 | 0.080 |
Why?
|
Intracranial Aneurysm | 1 | 2019 | 1276 | 0.080 |
Why?
|
Birth Weight | 3 | 2023 | 2097 | 0.080 |
Why?
|
Optic Disk | 1 | 2013 | 421 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2024 | 5253 | 0.080 |
Why?
|
Cohort Studies | 6 | 2022 | 41335 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2021 | 2526 | 0.080 |
Why?
|
Joint Instability | 1 | 2016 | 795 | 0.080 |
Why?
|
Oregon | 1 | 2008 | 148 | 0.080 |
Why?
|
Administration, Oral | 1 | 2016 | 4035 | 0.080 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15289 | 0.080 |
Why?
|
Radiation Injuries | 1 | 2016 | 1183 | 0.080 |
Why?
|
Patient Readmission | 1 | 2022 | 3323 | 0.080 |
Why?
|
MEDLINE | 1 | 2008 | 119 | 0.070 |
Why?
|
Computer Simulation | 5 | 2024 | 6218 | 0.070 |
Why?
|
Models, Statistical | 3 | 2017 | 5075 | 0.070 |
Why?
|
Angiogenesis Inhibitors | 2 | 2016 | 2049 | 0.070 |
Why?
|
Total Quality Management | 1 | 2008 | 265 | 0.070 |
Why?
|
Liver Cirrhosis | 1 | 2017 | 1931 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5649 | 0.070 |
Why?
|
Societies, Medical | 3 | 2024 | 3905 | 0.070 |
Why?
|
Workload | 1 | 2013 | 847 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1535 | 0.070 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 12965 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11712 | 0.070 |
Why?
|
Dilatation, Pathologic | 2 | 2018 | 527 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2019 | 14495 | 0.060 |
Why?
|
Risk Factors | 8 | 2023 | 74359 | 0.060 |
Why?
|
Tumor Microenvironment | 1 | 2018 | 3844 | 0.060 |
Why?
|
Prospective Studies | 7 | 2023 | 54303 | 0.060 |
Why?
|
Treatment Outcome | 7 | 2023 | 65017 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4925 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2014 | 5201 | 0.060 |
Why?
|
Lower Extremity | 2 | 2023 | 1194 | 0.060 |
Why?
|
Exercise | 1 | 2020 | 5787 | 0.060 |
Why?
|
Papillomaviridae | 2 | 2023 | 1117 | 0.060 |
Why?
|
Colposcopy | 1 | 2023 | 150 | 0.050 |
Why?
|
Survival Rate | 3 | 2018 | 12808 | 0.050 |
Why?
|
Young Adult | 7 | 2018 | 58741 | 0.050 |
Why?
|
Child | 8 | 2024 | 79806 | 0.050 |
Why?
|
Liver | 1 | 2017 | 7509 | 0.050 |
Why?
|
X-Rays | 1 | 2022 | 307 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2018 | 58995 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7818 | 0.050 |
Why?
|
Monte Carlo Method | 2 | 2017 | 1257 | 0.050 |
Why?
|
Research Design | 2 | 2014 | 6180 | 0.050 |
Why?
|
Brain Infarction | 1 | 2023 | 292 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2019 | 1440 | 0.050 |
Why?
|
Periodicals as Topic | 1 | 2012 | 1469 | 0.050 |
Why?
|
Cluster Analysis | 1 | 2007 | 2698 | 0.040 |
Why?
|
Positron-Emission Tomography | 4 | 2021 | 6465 | 0.040 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2018 | 833 | 0.040 |
Why?
|
Mutation | 3 | 2024 | 29932 | 0.040 |
Why?
|
Adrenal Glands | 1 | 2022 | 554 | 0.040 |
Why?
|
Nepal | 1 | 2021 | 301 | 0.040 |
Why?
|
Kinetics | 2 | 2019 | 6377 | 0.040 |
Why?
|
Utilization Review | 1 | 2021 | 383 | 0.040 |
Why?
|
Netherlands | 1 | 2024 | 2213 | 0.040 |
Why?
|
Risk Assessment | 3 | 2023 | 24123 | 0.040 |
Why?
|
Breast | 2 | 2019 | 1963 | 0.040 |
Why?
|
Limb Salvage | 1 | 2022 | 465 | 0.040 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2019 | 92 | 0.040 |
Why?
|
Receptors, GABA | 1 | 2021 | 305 | 0.040 |
Why?
|
Hand Bones | 1 | 2018 | 13 | 0.040 |
Why?
|
DNA Helicases | 1 | 2024 | 854 | 0.040 |
Why?
|
Troponin T | 1 | 2023 | 774 | 0.040 |
Why?
|
Vagina | 1 | 2024 | 837 | 0.040 |
Why?
|
Hemizygote | 1 | 2017 | 28 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 485 | 0.040 |
Why?
|
Critical Illness | 2 | 2021 | 2709 | 0.040 |
Why?
|
Edema | 1 | 2022 | 769 | 0.040 |
Why?
|
Carbon Tetrachloride | 1 | 2017 | 72 | 0.040 |
Why?
|
Health Services | 1 | 2022 | 753 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4775 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5643 | 0.040 |
Why?
|
Ankle | 1 | 2020 | 350 | 0.040 |
Why?
|
Quinazolines | 2 | 2013 | 1363 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2021 | 610 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1180 | 0.030 |
Why?
|
Half-Life | 1 | 2017 | 652 | 0.030 |
Why?
|
Quality Control | 1 | 2019 | 828 | 0.030 |
Why?
|
Expert Systems | 1 | 2016 | 79 | 0.030 |
Why?
|
Diffusion | 1 | 2017 | 813 | 0.030 |
Why?
|
Permeability | 1 | 2017 | 719 | 0.030 |
Why?
|
Palate, Soft | 1 | 2016 | 100 | 0.030 |
Why?
|
Antineoplastic Protocols | 1 | 2015 | 50 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2024 | 39261 | 0.030 |
Why?
|
Internationality | 1 | 2021 | 1004 | 0.030 |
Why?
|
Infant, Low Birth Weight | 1 | 2020 | 859 | 0.030 |
Why?
|
Abdomen | 1 | 2021 | 1130 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4591 | 0.030 |
Why?
|
Models, Theoretical | 2 | 2021 | 3562 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 587 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 782 | 0.030 |
Why?
|
United States | 4 | 2020 | 72461 | 0.030 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2016 | 881 | 0.030 |
Why?
|
Arthroscopy | 1 | 2021 | 960 | 0.030 |
Why?
|
Skull | 1 | 2018 | 815 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2017 | 2262 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 2016 | 1628 | 0.030 |
Why?
|
DNA Modification Methylases | 1 | 2013 | 209 | 0.030 |
Why?
|
Reference Values | 1 | 2020 | 4925 | 0.030 |
Why?
|
Platelet Count | 1 | 2015 | 777 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1607 | 0.030 |
Why?
|
Logistic Models | 2 | 2021 | 13314 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2024 | 2821 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3446 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 25942 | 0.030 |
Why?
|
Thoracic Neoplasms | 1 | 2014 | 266 | 0.030 |
Why?
|
Argentina | 1 | 2013 | 245 | 0.030 |
Why?
|
Perfusion | 1 | 2016 | 1376 | 0.020 |
Why?
|
Motion | 1 | 2015 | 779 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2013 | 345 | 0.020 |
Why?
|
Video Recording | 1 | 2017 | 955 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2024 | 2884 | 0.020 |
Why?
|
Life Tables | 1 | 2011 | 365 | 0.020 |
Why?
|
Seizures | 1 | 2024 | 2917 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 1431 | 0.020 |
Why?
|
Diabetic Retinopathy | 1 | 2020 | 1268 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3113 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22053 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2023 | 3387 | 0.020 |
Why?
|
Information Dissemination | 1 | 2019 | 1131 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2192 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13502 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3529 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2622 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2015 | 805 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9631 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 8056 | 0.020 |
Why?
|
Medical Oncology | 1 | 2021 | 2313 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5791 | 0.020 |
Why?
|
Prostate | 1 | 2017 | 1793 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2016 | 2897 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2016 | 818 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2021 | 3811 | 0.020 |
Why?
|
Incidence | 2 | 2020 | 21392 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8803 | 0.020 |
Why?
|
Fluorescein Angiography | 1 | 2013 | 1045 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5794 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2852 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2017 | 2733 | 0.020 |
Why?
|
PubMed | 1 | 2008 | 128 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3736 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3804 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6828 | 0.020 |
Why?
|
Hemodynamics | 1 | 2016 | 4174 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2013 | 1613 | 0.020 |
Why?
|
Probability | 1 | 2011 | 2475 | 0.020 |
Why?
|
Child, Preschool | 2 | 2018 | 42063 | 0.020 |
Why?
|
Educational Status | 1 | 2013 | 2515 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 2385 | 0.020 |
Why?
|
Image Enhancement | 1 | 2015 | 2881 | 0.010 |
Why?
|
Comorbidity | 1 | 2019 | 10551 | 0.010 |
Why?
|
Carcinoma | 1 | 2016 | 2331 | 0.010 |
Why?
|
Transcription Factors | 1 | 2024 | 12103 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2803 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6068 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10344 | 0.010 |
Why?
|
Adolescent | 3 | 2018 | 87810 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2802 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2011 | 2943 | 0.010 |
Why?
|
Smoking | 1 | 2019 | 9073 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8555 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29749 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8624 | 0.010 |
Why?
|
Rats | 1 | 2017 | 23711 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10790 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5889 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6544 | 0.010 |
Why?
|
Time Factors | 1 | 2022 | 40165 | 0.010 |
Why?
|
Hypertension | 1 | 2019 | 8594 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3865 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 5961 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18137 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2011 | 11152 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18416 | 0.010 |
Why?
|
Internship and Residency | 1 | 2014 | 5870 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81208 | 0.010 |
Why?
|
Animals | 1 | 2017 | 167963 | 0.000 |
Why?
|